Literature DB >> 15685506

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy.

Yoshinobu Kanesaki1, Daisuke Suzuki, Goro Uehara, Masao Toyoda, Tetsuo Katoh, Hideto Sakai, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: In diabetic nephropathy (DN) small vessels are frequently observed around the glomerular vascular pole in addition to normal afferent and efferent arterioles; this is regarded as neovascularization . Because vascular endothelial growth factor (VEGF) promotes vascular generation, the authors investigated the relationship between glomerular VEGF gene expression and structural glomerular changes in the early stage of human DN.
METHODS: Kidney specimens were obtained from 18 type 2 DN patients by open renal biopsy. Additional vessels were distinguished by light microscopy as either afferent or efferent arterioles. Glomerular VEGF messenger RNA expression was determined by using in situ hybridization. The mesangial matrix area was quantified, and the ratio of the mesangial matrix area to the whole glomerular area was calculated to determine the mesangial matrix index (MMI).
RESULTS: There were significantly more glomeruli with extra vessels in DN than in normal kidneys. The degree of neovascularization was significantly increased in DN and correlated with the magnitude of VEGF messenger RNA expression (r 2 = 0.46, P = 0.010) and MMI (r 2 = 0.45, P = 0.0093).
CONCLUSION: These findings suggest that glomerular VEGF may be involved in structural changes in human DN at an early stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685506     DOI: 10.1053/j.ajkd.2004.09.020

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  42 in total

1.  The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats.

Authors:  Peter Celec; Július Hodosy; Roman Gardlík; Michal Behuliak; Roland Pálffy; Marek Pribula; Peter Jáni; Ján Turňa; Katarína Sebeková
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Abdolrahim Nikzamir; Alireza Esteghamati; Amir Abbas Hammedian; Touraj Mahmoudi
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

3.  Efficacy of low-density lipoprotein apheresis combined with corticosteroids for cholesterol crystal embolism.

Authors:  Katsuya Ishiyama; Toshinobu Sato; Takuhiro Yamaguchi; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2016-04-21       Impact factor: 2.801

4.  Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.

Authors:  Youli Wang; Kathleen Heilig; Thomas Saunders; Andrew Minto; Dilip K Deb; Anthony Chang; Frank Brosius; Carmela Monteiro; Charles W Heilig
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-07

5.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

6.  Podocyte and endothelial-specific elimination of BAMBI identifies differential transforming growth factor-β pathways contributing to diabetic glomerulopathy.

Authors:  Han Lai; Anqun Chen; Hong Cai; Jia Fu; Fadi Salem; Yu Li; John C He; Detlef Schlondorff; Kyung Lee
Journal:  Kidney Int       Date:  2020-04-26       Impact factor: 10.612

Review 7.  Vascular endothelial growth factor and diabetic nephropathy.

Authors:  Sheldon Chen; Fuad N Ziyadeh
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

8.  Abnormal angiogenesis in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Tomoki Kosugi; Masakazu Haneda; Christopher J Rivard; David A Long
Journal:  Diabetes       Date:  2009-07       Impact factor: 9.461

9.  Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2.

Authors:  Barbara Ruszkowska-Ciastek; Alina Sokup; Tomasz Wernik; Piotr Rhone; Krzysztof Góralczyk; Kornel Bielawski; Agata Fijałkowska; Aleksandra Nowakowska; Elżbieta Rhone; Danuta Rość
Journal:  J Zhejiang Univ Sci B       Date:  2015-09       Impact factor: 3.066

10.  CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy.

Authors:  Eunyoung Tak; Douglas Ridyard; Jae-Hwan Kim; Michael Zimmerman; Tilmann Werner; Xiaoxin X Wang; Uladzimir Shabeka; Seong-Wook Seo; Uwe Christians; Jost Klawitter; Radu Moldovan; Gabriela Garcia; Moshe Levi; Volker Haase; Katya Ravid; Holger K Eltzschig; Almut Grenz
Journal:  J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.